Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/27/25 16:06 | 5/22/25 | KALV | Health | Drug | Pharmaceutical Preparations | Audhya Paul K. | MA | O | Chief Me | 6 | M.d | 89 | 3.52 | 0 | 25 | 29 | 113 | D | ||||||||||||||
5/27/25 16:06 | 5/23/25 | KALV | Health | Drug | Pharmaceutical Preparations | Audhya Paul K. | MA | O | Chief Me | 6 | S.d | -89 | 3.52 | 0 | -25 | 113 | D | |||||||||||||||
5/27/25 16:05 | 5/22/25 | KALV | Health | Drug | Pharmaceutical Preparations | Yea Christopher | MA | O | Chief De | 6 | M.d | 80 | 4.47 | 0 | 18 | 22 | 98 | D | ||||||||||||||
5/27/25 16:05 | 5/23/25 | KALV | Health | Drug | Pharmaceutical Preparations | Yea Christopher | MA | O | Chief De | 6 | S.d | -80 | 4.47 | 0 | -18 | 98 | D | |||||||||||||||
5/23/25 16:24 | 5/21/25 | KALV | Health | Drug | Pharmaceutical Preparations | Palleiko Benjamin L | MA | DO | CEO | 6 | M.d | 244 | 3.55 | 0 | 69 | 29 | 307 | D | ||||||||||||||
5/23/25 16:24 | 5/22/25 | KALV | Health | Drug | Pharmaceutical Preparations | Palleiko Benjamin L | MA | DO | CEO | 6 | S.d | -244 | 3.55 | 0 | -69 | 307 | D | |||||||||||||||
4/11/25 17:22 | 4/9/25 | KALV | Health | Drug | Pharmaceutical Preparations | Venrock Healthcare Capital Partners Iii, L.P. | NY | T | 1 | P | 236 | 9.42 | 0 | 25 | 0 | 5,304 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |